Funding Opportunities

Current funding opportunities related to TB and HIV, expired RFAs will be hidden after closing date. Sort using the tags menu to the right.

Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01/R21 Clinical Trial Not Allowed), expires: 05/08/2021

Application Due Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.

https://grants.nih.gov/grants/guide/pa-files/PA-18-725.html

https://grants.nih.gov/grants/guide/pa-files/PA-18-724.html

Ecology and Evolution of Infectious Diseases (EEID), due annually in November

Full Proposal Deadline Date: November 20, 2019

The Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and socio-ecological principles and processes that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; the cultural, social, behavioral, and economic dimensions of disease transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric diseases of either terrestrial or freshwater systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to develop the appropriate multidisciplinary team, including for example, modelers, bioinformaticians, genomics researchers, social scientists, economists, epidemiologists, entomologists, parasitologists, microbiologists, bacteriologists, virologists, pathologists or veterinarians, with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.

https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269

Notice of NIH Participation: https://grants.nih.gov/grants/guide/notice-files/NOT-TW-19-007.html

Bloomberg Initiative To Reduce Tobacco Use Grants Program

The Bloomberg Initiative to Reduce Tobacco use Grants Program utilizes World Bank country income groups to establish eligibility to apply for a grant. Organizations from low- and middle-income countries are welcome to apply. This includes low-income, lower-middle-income, and upper-middle-income countries.

Open Grant Round (OGR) – An international competitive grant round, open to applicants from any low or middle-income country. OGR applications should focus on a national policy gap in their country in the PWER areas of MPOWER, or FCTC Article 5.3 policy (this must be in association with strengthening MPOWER policies).

Strategic Grant Round (SGR) – This round is only open to applicants from the ten priority countries, and is focused on the priority issues identified for each of those countries.

The ten priority countries are:

  1. China
  2. India
  3. Indonesia
  4. Bangladesh
  5. Pakistan
  6. Vietnam
  7. Philippines
  8. Brazil
  9. Ukraine
  10. Mexico

https://tobaccocontrolgrants.org/Apply-For-A-Grant

NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed), expires: 01/08/2021

Application Due Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.

The NIMH Exploratory/Developmental Grant program supports exploratory and high-risk research projects that fall within the NIMH mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. The preliminary work from these studies could lead to a major impact on biomedical, behavioral, or clinical mental health research, or on the delivery of mental health care.

https://grants.nih.gov/grants/guide/pa-files/PA-18-350.html

Dissemination and Implementation Research in Health (R01/R21 Clinical Trial Optional), expires: 05/08/2022

Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. 

R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-274.html

R21: https://grants.nih.gov/grants/guide/pa-files/par-19-275.html

R03: https://grants.nih.gov/grants/guide/pa-files/par-19-276.html

Emerging Global Leader Award (K43), expires: 11/05/2020


Application Due Date(s): November 7, 2019 and November 4, 2020 by 5:00 PM local time of applicant organization.

The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-len…, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

https://grants.nih.gov/grants/guide/pa-files/PAR-19-098.html

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed), expires: 07/29/2023

Application Due Date(s): July 28, 2021; July 28, 2022; July 28, 2023, by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.

https://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html

HIV Prevention Trials Network (HPTN) Scholars Program (Domestic and International), due annually January

Application due:

  • Initial proposal drafts for Domestic Scholars are due 5 January 2018 and full applications are due 19 January 2018
  • Initial proposal drafts for International Scholars are due 29 January 2018 and full applications are due 12 February 2018

The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute on Drug Abuse (NIDA). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research. In the domestic program, successful applicants will be Investigators who have received their terminal degree (MD, Phd, etc). For the international version, current MD, PhD, and MBChB students may apply, along with individuals having already graduated with their terminal degree. In both programs, applicants should desire to work with a mentor scientist in the Network to complete a research project based upon an existing HPTN research study.

https://hptn.org/research/scholars

Vanderbilt Trans-Institutional Programs (Internal Opportunity), due annually 10/30

https://www.vanderbilt.edu/provost/occi/tips.php

Vanderbilt Initiative Awards (ViA):

  • Small-scale or new initiatives that showcase potential to become a major hub of activity - center or institute - that will advance the core missions of Vanderbilt
  • Provide seed funding up to $100,000 per year.
  • Provide faculty the opportunity to pursue innovative ideas for discovery and learning with colleagues from diverse disciplines.
  • Must include collaborators from multiple schools and colleges.* 

Vanderbilt Reinvestment Awards (VRA):

  • Awarded to existing centers and institutes that facilitate learning collaborations across campus.
  • Assist collaborations taking a critical next step in order to ensure continued success.
  • Funding varies on a case-by-case basis.
  • Must secure partnerships with respective deans as part of the full-proposal submission process.